Literature DB >> 17321858

Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.

Murugappan Ramanathan1, Andrew P Lane.   

Abstract

Chronic rhinosinusitis (CRS) is one of the most common health problems in the United States. Medical therapy and surgery are successful in treating the majority of patients with sinusitis; however, CRS patients recalcitrant to traditional therapy are increasingly prevalent. Although traditionally this illness could be explained by sinus ostial obstruction and persistent bacterial infection, the rhinologic literature over the years has suggested a significant underlying inflammatory component. Adaptive immune components, including lymphocytes and their associated cytokines, have been the subject of most research in chronic nasal inflammation. A recent appreciation of the importance of the innate immune system is leading to new areas of investigation regarding the pathogenesis of CRS. This review will outline our current knowledge of sinonasal innate immunity, the role of innate immunity in the pathogenesis of CRS, and potential therapeutic targets in the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321858     DOI: 10.1016/j.otohns.2006.11.011

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  39 in total

Review 1.  Bitter and sweet taste receptors in the respiratory epithelium in health and disease.

Authors:  Robert J Lee; Noam A Cohen
Journal:  J Mol Med (Berl)       Date:  2014-11-13       Impact factor: 4.599

2.  Otolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014).

Authors:  Howard W Francis; Ira Papel; Ioan Lina; Wayne Koch; David Tunkel; Paul Fuchs; Sandra Lin; David Kennedy; Robert Ruben; Fred Linthicum; Bernard Marsh; Simon Best; John Carey; Andrew Lane; Patrick Byrne; Paul Flint; David W Eisele
Journal:  Laryngoscope       Date:  2015-08-22       Impact factor: 3.325

3.  Bactericidal antibiotics promote reactive oxygen species formation and inflammation in human sinonasal epithelial cells.

Authors:  Michael A Kohanski; Anuj Tharakan; Andrew P Lane; Murugappan Ramanathan
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-01       Impact factor: 3.858

4.  Plasma RANTES and eotaxin levels are correlated with the severity of chronic rhinosinusitis.

Authors:  Pin-Zhir Chao; Chi-Ming Chou; Chen-Ho Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-24       Impact factor: 2.503

5.  Chitin stimulates expression of acidic mammalian chitinase and eotaxin-3 by human sinonasal epithelial cells in vitro.

Authors:  Ashley Lalaker; Louis Nkrumah; Won-Kyung Lee; Murugappan Ramanathan; Andrew P Lane
Journal:  Am J Rhinol Allergy       Date:  2009 Jan-Feb       Impact factor: 2.467

6.  Chronic rhinosinusitis as a multifactorial inflammatory disorder.

Authors:  Stella Lee; Andrew P Lane
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

7.  Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis.

Authors:  Xin Wang; Chunyuan Zhao; Wenjun Ji; Yuan Xu; Huamin Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

8.  Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis.

Authors:  Shilpy Sharma; So Watanabe; Anita Sivam; JiangHong Wang; Samantha J Neuwirth; Rosanne I Perez; Marcella De Tineo; Fuad M Baroody; Robert M Naclerio; Jayant M Pinto
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

9.  Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components.

Authors:  Robert J Lee; Bei Chen; Kevin M Redding; Robert F Margolskee; Noam A Cohen
Journal:  Innate Immun       Date:  2013-09-17       Impact factor: 2.680

Review 10.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.